32834825 2025-01-01 2025-12-31 1 32834825 2024-01-01 2024-12-31 1 32834825 2002-01-01 2002-12-31 1 32834825 2001-01-01 2001-12-31 1 32834825 2000-01-01 2000-12-31 1 32834825 2025-01-01 2025-12-31 32834825 2025-01-01 2025-12-31 1 32834825 2025-01-01 2025-12-31 1 32834825 2025-01-01 2025-12-31 2 32834825 2025-01-01 2025-12-31 1 32834825 2025-01-01 2025-12-31 2 32834825 2025-01-01 2025-12-31 3 32834825 2002-01-01 2002-12-31 32834825 2001-01-01 2001-12-31 32834825 2000-01-01 2000-12-31 32834825 2024-01-01 2024-12-31 32834825 2002-12-31 32834825 2001-12-31 32834825 2000-12-31 32834825 2025-12-31 32834825 2024-12-31 32834825 2024-01-01 d:ContributedCapitalMember 32834825 2024-01-01 d:RetainedEarningsMember 32834825 2024-01-01 2024-12-31 d:RetainedEarningsMember 32834825 2025-01-01 d:ContributedCapitalMember 32834825 2025-01-01 d:RetainedEarningsMember 32834825 2025-01-01 2025-12-31 d:RetainedEarningsMember 32834825 2025-12-31 d:ContributedCapitalMember 32834825 2025-12-31 d:RetainedEarningsMember 32834825 2025-01-01 32834825 2024-01-01 32834825 2025-01-01 d:AcquiredIntangibleAssetsMember 32834825 2025-12-31 d:AcquiredIntangibleAssetsMember 32834825 2025-01-01 2025-12-31 d:AcquiredIntangibleAssetsMember 32834825 2025-01-01 d:LandAndBuildingsMember 32834825 2025-01-01 d:PlantAndMachineryMember 32834825 2025-01-01 d:FixturesFittingsToolsAndEquipmentMember 32834825 2025-01-01 d:PropertyPlantAndEquipmentInProgressMember 32834825 2025-01-01 2025-12-31 d:LandAndBuildingsMember 32834825 2025-01-01 2025-12-31 d:PlantAndMachineryMember 32834825 2025-01-01 2025-12-31 d:FixturesFittingsToolsAndEquipmentMember 32834825 2025-01-01 2025-12-31 d:PropertyPlantAndEquipmentInProgressMember 32834825 2025-12-31 d:LandAndBuildingsMember 32834825 2025-12-31 d:PlantAndMachineryMember 32834825 2025-12-31 d:FixturesFittingsToolsAndEquipmentMember 32834825 2025-12-31 d:PropertyPlantAndEquipmentInProgressMember 32834825 2025-01-01 d:InvestmentsInGroupEnterprisesMember 32834825 2025-12-31 d:InvestmentsInGroupEnterprisesMember 32834825 2025-01-01 2025-12-31 d:SubsidiaryMember 1 32834825 2025-12-31 d:SubsidiaryMember 1 iso4217:DKK xbrli:pure Current ratio Current ratio Current ratio Current ratio Current ratio Årsrapport 30700228 EY Godkendt Revisionspartnerselskab  Bavnehøjvej 5 6700 Esbjerg 2025-01-01 2025-12-31 2024-01-01 2024-12-31 32834825 ZPD A/S H E Bluhmes Vej  63 6700 Esbjerg 2010-03-04 Esbjerg EY Godkendt Revisionspartnerselskab 30700228 Bavnehøjvej  5 6700 Esbjerg Danmark +45 73 23 30 00 2026-03-19 Masakazu Sakurai Regnskabsklasse B Revisionspåtegning Grundlag for konklusion Konklusion true true 2026-03-19 2026-03-19 CaseWare Working Papers Today, the Board of Directors and the Executive Board have discussed and approved the annual report of ZPD A/S for the financial year 1 January - 31 December 2025. The annual report is prepared in accordance with the Danish Financial Statements Act. In our opinion, the financial statements give a true and fair view of the financial position of the Company at 31 December 2025 and of the results of the Company's operations and cash flows for the financial year 1 January - 31 December 2025. Further, in our opinion, the Management's review gives a fair review of the matters discussed in the Management's review. We recommend that the annual report be approved at the annual general meeting. Esbjerg Frank Marek Hiroyuki Shinya Masakazu Sakurai Chairman Frank Marek Ken Motegi To the shareholder of ZPD A/S We have audited the financial statements of ZPD A/S for the financial year 1 January - 31 December 2025,  which comprise income statement, balance sheet, statement of changes in equity, cash flow statement and notes, including accounting policies. The financial statements are prepared in accordance with the Danish Financial Statements Act.In our opinion, the financial statements give a true and fair view of the financial position of the Company at 31 December 2025 and of the results of the Company's operations as well as the cash flows for the financial year 1 January - 31 December 2025 in accordance with the Danish Financial Statements Act. We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the "Auditor's responsibilities for the audit of the financial statements" section of our report. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.IndependenceWe are independent of the Company in accordance with the International Ethics Standards Board for Accountants' International Code of Ethics for Professional Accountants (IESBA Code) and the additional ethical requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements and the IESBA Code. Management is responsible for the preparation of financial statements that give a true and fair view in accordance with the Danish Financial Statements Act and for such internal control as Management determines is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.In preparing the financial statements, Management is responsible for assessing the Company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting in preparing the financial statements unless Management either intends to liquidate the Company or to cease operations, or has no realistic alternative but to do so. Our objectives are to obtain reasonable assurance as to whether the financial statements as a whole are free from material misstatement, whether due to fraud or error and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs and the additional requirements applicable in Denmark will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of the financial statements.As part of an audit conducted in accordance with ISAs and the additional requirements applicable in Denmark, we exercise professional judgement and maintain professional scepticism throughout the audit. We also:Identify and assess the risks of material misstatement of the financial statements, whether due to fraud or error, design and perform audit procedures responsive to those risks and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error as fraud may involve collusion, forgery, intentional omissions, misrepresentations or the override of internal control.Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control.Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by Management.Conclude on the appropriateness of Management's use of the going concern basis of accounting in preparing the financial statements and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the Company's ability to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditor's report to the related disclosures in the financial statements or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditor's report. However, future events or conditions may cause the Company to cease to continue as a going concern.Evaluate the overall presentation, structure and contents of the financial statements, including the note disclosures, and whether the financial statements represent the underlying transactions and events in a manner that gives a true and fair view.We communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit. Management is responsible for the Management's review.Our opinion on the financial statements does not cover the Management's review, and we do not express any form of assurance conclusion thereon.In connection with our audit of the financial statements, our responsibility is to read the Management's review and, in doing so, consider whether the Management's review is materially inconsistent with the financial statements or our knowledge obtained during the audit, or otherwise appears to be materially misstated.Moreover, it is our responsibility to consider whether the Management's review provides the information required under the Danish Financial Statements Act.Based on the work we have performed, we conclude that the Management's review is in accordance with the financial statements and has been prepared in accordance with the requirements of the Danish Financial Statement Act. We did not identify any material misstatement of the Management's review. Esbjerg Mads Klausen State Authorised Public Accountant mne46588 43788000 37256000 35200000 12925000 9615000 9581000 2278000 3174000 2185000 -665000 -980000 11824000 7067000 6963000 209254000 197015000 189623000 -22995000 -4937000 -4263000 -4984000 -6218000 197056000 185232000 178165000 1587.6 2613.3 2469.3 2104.5 2020.1 92.2 94.5 94.2 94.0 94.0 4.8 6.3 6.2 3.9 4.0 39 35 35 The financial ratios stated under "Financial highlights" have been calculated as follows:Operating profit/loss Profit/loss before net financials +/- Other operating income and other operating expensesCurrent ratio Current assets x 100Current liabilitiesEquity ratio Equity, year-end x 100Total equity and liabilities, year-endReturn on equity Profit/loss after tax x 100Average equity ZPD A/S produces mainly pharmaceutical and food grade products and sells them abroad. The income statement for 2025 shows a profit of DKK 10,220 thousand against a profit of DKK 12,864 thousand last year, and the balance sheet at 31 December 2025 shows equity of DKK 217,641 thousand.     In the annual report for 2024 Management expected a profit for 2025 on the same level as 2024. The profit is lower than expected due to sales mix, increased maintenance and cost of raw materials. Management considers the Company's financial performance in the year satisfactory. The Company has no special risks apart from the risks that trading primarily with one large customer, the parent company, may lead to.   The Company's transactions in foreign currency are mainly in euro. Consequently, no significant risks related to transactions in foreign currency have been identified. No events materially affecting the assessment of the Annual Report have occurred after the balance sheet date. Management expects activities and profit before tax for 2026 in the same level as 2025. The expectations are based on current market situation, expected production costs and current interest rates. 52704000 49315000 37675000 32406000 4279000 3615000 93000 34000 10657000 13260000 3426000 3579000 1148000 405000 12935000 16434000 2715000 3570000 10220000 12864000 1500000 1000000 8720000 11864000 1038000 1448000 1038000 1448000 7112000 5957000 31401000 11595000 3862000 4247000 1293000 3303000 43668000 25102000 60000 60000 60000 60000 44766000 26610000 27990000 18414000 1156000 882000 15875000 19673000 1048000 312000 46069000 39281000 1053000 3814000 33890000 19350000 2660000 737000 4215000 1303000 495000 194000 42313000 25398000 102904000 129751000 191286000 194430000 236052000 221040000 1000000 1000000 216641000 207921000 217641000 208921000 6362000 4679000 6362000 4679000 9282000 4003000 34000 80000 2733000 3357000 12049000 7440000 12049000 7440000 236052000 221040000 1000000 196057000 12864000 1000000 1000000 207921000 10220000 1500000 1000000 216641000 The share capital comprises 10,000 shares of DKK 100 each. All shares rank equally.The Company's share capital has remained DKK 1,000 thousand over the past 5 years. 10220000 12864000 4805000 3936000 -17126000 15742000 -2101000 32542000 3426000 3099000 1148000 49000 3000000 3158000 -2823000 32434000 0 247000 22995000 4937000 471000 447000 -23794000 15370000 1270000 -20107000 1500000 1000000 -1500000 -1000000 -3053000 11327000 38737000 27410000 35684000 38737000 The annual report of ZPD A/S has been presented in accordance with the provisions of the Danish Financial Statements Act as regards medium-sized reporting class C enterprises. Pursuant to section 110(1) of the Danish Financial Statements Act, the Company has not prepared consolidated financial statements. The accounting policies used in the preparation of the financial statements are consistent with those of last year. Assets are recognised in the balance sheet when it is probable that future economic benefits will flow to the Company and the value of the asset can be reliably measured.Liabilities are recognised in the balance sheet when an outflow of economic benefits is probable and when the value of the liability can be reliably measured.On initial recognition, assets and liabilities are measured at cost. Subsequently, assets and liabilities are measured as described below for each individual item.Certain financial assets and liabilities are measured at amortised cost implying the recognition of a constant effective interest rate to maturity. Amortised cost is calculated as initial cost minus any principal repayments and plus or minus the cumulative amortisation of any difference between cost and nominal amount.In recognising and measuring assets and liabilities, any gains, losses and risks occurring prior to the presentation of the annual report that evidence conditions existing at the balance sheet date are taken into account.Income is recognised in the income statement as earned, including value adjustments of financial assets and liabilities measured at fair value or amortised cost. Equally, costs incurred to generate the year's earnings are recognised, including depreciation, impairment losses and provisions as well as reversals as a result of changes in accounting estimates of amounts which were previously recognised in the income statement. Reporting currencyThe financial statements are presented in Danish kroner (DKK'000). Transactions denominated in foreign currencies are translated into Danish kroner at the exchange rate at the date of the transaction.Receivables and payables and other monetary items denominated in foreign currencies are translated at the exchange rate at the balance sheet date. The difference between the exchange rates at the balance sheet date and the date at which the receivable or payable arose or was recognised in the most recent financial statements is recognised in the income statement as financial income or financial expenses. The Company has chosen IAS 11/IAS 18 as interpretation for revenue recognition.Income from the sale of goods for resale and finished goods is recognised in the income statement when delivery and transfer of risk to the buyer have taken place and provided that the income can be reliably measured and is expected to be received.Revenue is measured at the fair value of the agreed consideration excluding VAT and taxes charged on behalf of third parties. All discounts and rebates granted are recognised in revenue. In accordance with the Danish Financial Statements Act section 32 revenue, other operating income, cost of raw materials and consumables and other external costs are aggregated in one line refered to as gross margin. Other operating income comprises items secondary to the activities of the Company, including gains on disposal of intangible assets and property, plant and equipment. Cost of sales includes the expenses relating to raw materials and consumables used in generating the year's revenue. Other external expenses include the year's expenses relating to the entity's core activities, including expenses relating to distribution, sale, advertising, administration, premises, bad debts, payments under operating leases, etc. Staff costs include wages and salaries, including compensated absence and pensions, as well as other social security contributions, etc. made to the entity's employees. The item is net of refunds made by public authorities. The item comprises armortisation of software and depreciation of property, plant and equipment.The basis of depreciation, which is calculated as cost less any residual value, is depreciated on a straight line basis over the expected useful life.Where individual components of an item of software or property, plant and equipment have different useful lives, they are accounted for as separate items, which are depreciated separately.Buildings 10-50 yearsPlant and machinery 5-10 yearsOther fixtures and fittings, tools and equipment 4-10 yearsAcquired intangible assets (software) 3-10 years Depreciation is based on the residual value of the asset and is reduced by impairment losses, if any. The depreciation period and the residual value are determined at the acquisition date and are reassessed annually. Where the residual value exceeds the carrying amount of the asset, no further depreciation charges are recognised.In the case of changes in the depreciation period or the residual value, the effect on the depreciation charges is recognised prospectively as a change in accounting estimates.Land is not depreciated. Other operating expenses comprise items of a secondary nature relative to the Company's core activities, including losses on the sale of fixed assets. The item includes dividend received from group entities in so far as the dividend does not exceed the accumulated earnings in the group entity in the period of ownership. Financial income and expenses are recognised in the income statements at the amounts that concern the financial year. Net financials include interest income and expenses as well as allowances and surcharges under the advance-payment-of-tax scheme, etc. The parent company is covered by the Danish rules on mandatory joint taxation of the Group's Danish group entities. Group entities are included in the joint taxation arrangement from the date at which they are included in the consolidated financial statements and up to the date when they are no longer consolidated.The parent company acts as management company for the joint taxation arrangement and consequently settles all corporate income tax payments with the tax authorities.On payment of joint taxation contributions, the Danish corporate income tax charge is allocated between the jointly taxed entities in proportion to their taxable income. Entities with tax losses receive joint taxation contributions from entities that have been able to use the tax losses to reduce their own taxable income.Tax for the year, which comprises the current income tax charge, joint taxation contributions and deferred tax adjustments, including adjustments arising from changes in tax rates, is recognised in the income statement as regards the portion that relates to the profit/loss for the year and directly in equity as regards the portion that relates to entries directly in equity. On initial recognition, intangible assets are measured at cost.Software costs that are recognised in the balance sheet are measured at cost less accumulated amortisation and impairment losses.Gains or losses arising from the sale of items of intangible assets are recognised in the income statement under 'Other operating income' or 'Other operating expenses', respectively. Gains and losses are calculated by reference to the difference between the selling price less selling expenses and the carrying amount at the time of sale. Property, plant and equipmentItems of property, plant and equipment are measured at cost less accumulated depreciation and impairment losses. Cost includes the acquisition price and costs directly related to the acquisition until the time at which the asset is ready for use.Cost comprises the purchase price and any costs directly attributable to the acquisition until the date when the asset is available for use. The cost of self-constructed assets comprises direct and indirect costs of materials, components, subsuppliers, and wages and salaries.Interest expense on loans to finance the production of property, plant and equipment which concerns the production period is included in cost. All other borrowing costs are recognised in the income statement.Gains or losses arising from the sale of items of property, plant and equipment are recognised in the income statement under 'Other operating income' or 'Other operating expenses', respectively. Gains and losses are calculated by reference to the difference between the selling price less selling expenses and the carrying amount at the time of sale. The Company has chosen IAS 17 as interpretation for classification and recognition of leases.On initial recognition, leases for assets that transfer substantially all the risks and rewards incident to the ownership to the Company (finance leases) are measured in the balance sheet at the lower of fair value and the present value of the future lease payments. In calculating the net present value, the interest rate implicit in the lease or the incremental borrowing rate is used as the discount factor. Assets held under finance leases are subsequently accounted for in the same way as the Company's other assets.The capitalised residual lease liability is recognised in the balance sheet as a liability, and the interest element of the lease payment is recognised in the income statement over the term of the lease.Leases that do not transfer substantially all the risks and rewards incident to the ownership to the Company are classified as operating leases. Payments relating to operating leases and any other rent agreements are recognised in the income statement over the term of the lease. The Company's aggregate liabilities relating to operating leases and other rent agreements are disclosed under "Contingent liabilities". Investments in group entities and associates are measured at cost, which includes the cost of acquisition calculated at fair value plus direct costs of acquisition. If there is evidence of impairment, an impairment test is conducted. Where the carrying amount exceeds the recoverable amount, a write-down is made to such lower value. The carrying amount of intangible assets,  property, plant and equipment and investments in group entities is assessed for impairment on an annual basis. Impairment tests are conducted on assets or groups of assets when there is evidence of impairment. The carrying amount of impaired assets is reduced to the higher of the net selling price and the value in use (recoverable amount). The recoverable amount is the higher of the net selling price of an asset and its value in use. The value in use is calculated as the present value of the expected net cash flows from the use of the asset or the group of assets and the expected net cash flows from the disposal of the asset or the group of assets after the end of the useful life.Previously recognised impairment losses are reversed when the reason for recognition no longer exists. Inventories are measured at cost in accordance with the FIFO method. Where the net realisable value is lower than cost, inventories are written down to this lower value.Goods for resale and raw materials and consumables are measured at cost, comprising purchase price plus delivery costs.Finished goods and work in progress are measured at cost, comprising the cost of raw materials, consumables, direct wages and salaries and indirect production overheads. Borrowing costs are not included in cost.The net realisable value of inventories is calculated as the sales amount less costs of completion and costs necessary to make the sale and is determined taking into account marketability, obsolescence and development in expected selling price. The Company has chosen IAS 39 as interpretation for impairment write-down of financial receivables.Receivables are measured at amortised cost.An impairment loss is recognised if there is objective evidence that a receivable is impaired. If there is objective evidence that an individual receivable has been impaired, an impairment loss is recognised on an individual basis.Impairment losses are calculated as the difference between the carrying amount of the receivables and the present value of the expected cash flows, including the realisable value of any collateral received. The effective interest rate for the individual receivable is used as discount rate. Prepayments recognised under "Assets" comprise prepaid expenses regarding subsequent financial reporting years. Cash comprise cash and short term securities which are readly convertible into cash and subject only to minor risks of changes in value. Proposed dividendsDividends proposed for the financial year are presented as a separate item under ‘Equity'. Dividends proposed for the financial year are presented as a separate item under ‘Equity'. Current tax payables and receivables are recognised in the balance sheet as the estimated income tax charge for the year, adjusted for prior-year taxes and tax paid on account.Deferred tax is measured according to the liability method on all temporary differences between the carrying amount and the tax base of assets and liabilities. However, deferred tax is not recognised on temporary differences relating to goodwill which is not deductible for tax purposes and on office premises and other items where temporary differences, apart from business combinations, arise at the date of acquisition without affecting either profit/loss for the year or taxable income. Where alternative tax rules can be applied to determine the tax base, deferred tax is measured based on Management's intended use of the asset or settlement of the liability, respectively.Deferred tax is measured according to the tax rules and at the tax rates applicable at the balance sheet date when the deferred tax is expected to crystallise as current tax. Deferred tax assets are recognised at the expected value of their utilisation; either as a set-off against tax on future income or as a set-off against deferred tax liabilities in the same legal tax entity. Changes in deferred tax due to changes in the tax rate are recognised in the income statement.As management company for all the entities in the joint taxation arrangement, the parent company is liable for payment of the group entities' income taxes vis à vis the tax authorities as the group entities pay their joint taxation contributions. Joint taxation contributions payable or receivable are recognised in the balance sheet as income tax receivables or payables. The Company has chosen IAS 39 as interpretation for liabilities.Other liabilities are measured at net realisable value. The cash flow statement shows the Company's net cash flows broken down according to operating, investing and financing activities, the year's changes in cash and cash equivalents as well as the cash and cash equivalents at the beginning and the end of the year.Cash flows from operating activities are calculated as the profit/loss for the year adjusted for non cash operating items, changes in working capital and paid corporate income tax.Cash flows from investing activities comprise payments in connection with acquisitions and disposals of entities and activities and of intangible assets, property, plant and equipment and investments.Cash flows from financing activities comprise changes in the size or composition of the Company's share capital and related expenses as well as raising of loans, repayment of interest bearing debt and payment of dividends to shareholders. Cash and cash equivalents comprise cash, short term bank loans and short term securities which are readily convertible into cash and which are subject only to insignificant risks of changes in value. No events materially affecting the assessment of the Annual Report have occurred after the balance sheet date. 31485000 27300000 3197000 2636000 527000 429000 2466000 2041000 37675000 32406000 48 42 Total remuneration to the Executive Board: DKK 3,346 thousand (2024: DKK 3,102). 15000 0 3411000 3579000 1032000 3643000 1683000 -73000 3302000 3302000 1854000 410000 2264000 1038000 25479000 53716000 9831000 3303000 1601000 3524000 841000 17029000 1000 29000 891000 0 0 18952000 87000 -19039000 27079000 76163000 9868000 1293000 19522000 42121000 5584000 0 445000 2670000 754000 0 0 29000 332000 0 19967000 44762000 6006000 0 7112000 31401000 3862000 1293000 60000 60000 60000 JoinHealth ApS Vejle 100.00 -308 -123 The Company has made credit facilities of up to DKK 2,000 thousand available for JoinHealth ApS, of which DKK 503 thousand was used at 31 December 2025. Prepayments include accrual of expenses relating to subsequent financial years, including software licenses etc. 4679000 4753000 6362000 4679000 Provision for deferred tax comprises deferred tax regarding inventories and acquired intangible assets as well as property, plant and equipment. Other contingent liabilities As management company, the Company is jointly taxed with other Danish group entities and is jointly and severally with other jointly taxed group entities for payment of income taxes as well as withholding taxes on interest, royalties and dividends falling due for payment. The Company has, as part of its normal course of business, entered into customary executory contracts. The Company has not provided any security or other collateral in assets at 31 December 2025. Parties exercising control Related partyDomicileBasis for control Zeria Pharmaceutical Co. Ltd.JapanParticipating interest Information about consolidated financial statements ParentDomicileRequisitioning of the parent company's consolidated financial statements Zeria Pharmaceutical Co. Ltd.Japanhttps://www.zeria.co.jp/english/ir/ Related party transactions The Company solely discloses related party transactions that have not been carried out on an arm's length basis, cf. section 98c(6) of the Danish Financial Statements Act. All transactions have been carried out on an arm's length basis. 4279000 3615000 -89000 75000 -3426000 -3579000 -1148000 -405000 2715000 3570000 6789000 -5771000 -14992000 9933000 -4655000 -38000 102904000 129751000 -67220000 -91014000